Holdings (as at 2025-07-02)
Percentage of net assets may not equal 100%
Security Name % of Net Assets
First Trust NYSE® Arca® Biotechnology Index Fund 99.92%
Holdings of FBT - First Trust NYSE® Arca® Biotechnology Index Fund
(as at 2025-07-02)
Security Name % of Net Assets
ACADIA Pharmaceuticals Inc. 4.49%
Neurocrine Biosciences, Inc. 4.39%
Alnylam Pharmaceuticals, Inc. 4.27%
Illumina, Inc. 4.13%
Exelixis, Inc. 3.87%
Exact Sciences Corporation 3.73%
Incyte Corporation 3.69%
Mettler-Toledo International Inc. 3.57%
Biogen Inc. 3.56%
Moderna, Inc. 3.56%
BioNTech SE (ADR) 3.46%
Bruker Corporation 3.38%
Natera, Inc. 3.36%
Genmab A/S (ADR) 3.35%
Waters Corporation 3.33%
Gilead Sciences, Inc. 3.32%
Alkermes Plc 3.31%
BeOne Medicines Ltd. (ADR) 3.27%
United Therapeutics Corporation 3.24%
Amgen Inc. 3.20%
Corcept Therapeutics Inc. 3.20%
Repligen Corporation 3.18%
BioMarin Pharmaceutical Inc. 3.10%
Regeneron Pharmaceuticals, Inc. 3.05%
Vertex Pharmaceuticals Incorporated 2.91%
argenx SE (ADR) 2.89%
Halozyme Therapeutics, Inc. 2.76%
Veracyte, Inc. 2.67%
Krystal Biotech, Inc. 2.64%
Sarepta Therapeutics, Inc. 1.10%
Dreyfus Government Cash Management (Institutional Shares) 0.09%
US Dollar 0.00%

Holdings are subject to change.

Commissions, management fees and expenses all may be associated with Exchange-Traded Fund investments. Please carefully read the prospectus of the fund before investing. Exchange-Traded funds are not guaranteed, their values change frequently and past performance may not be repeated.